See the DrugPatentWatch profile for cosentyx

Changing the dose of Cosentyx without consulting a healthcare professional can lead to several risks. Cosentyx, also known as secukinumab, is a prescription medication used to treat various conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. The drug works by targeting a specific protein in the body that contributes to inflammation and related symptoms [1].

Altering the dosage without medical guidance can result in the following risks:

1. Ineffective treatment: Changing the dose may lead to inadequate control of the underlying condition, as the new dosage might not be sufficient to manage the symptoms [2].
2. Overdose: Increasing the dosage without consulting a healthcare professional can result in an overdose, potentially causing adverse reactions and side effects [2].
3. Adverse reactions: Modifying the dosage can increase the risk of experiencing side effects, some of which may be severe or life-threatening [2].
4. Drug interactions: Unsupervised changes in dosage can lead to unexpected interactions with other medications, potentially causing harmful side effects [2].
5. Loss of treatment benefits: Abruptly changing the dosage can result in the loss of therapeutic benefits, as the body might not respond optimally to the new dosage [2].

It is crucial to consult a healthcare professional before making any changes to the Cosentyx dosage, as they can provide personalized guidance based on individual medical history, current medications, and specific health conditions [2].

Sources:
[1] "Secukinumab" (Cosentyx). DrugPatentWatch.com. <https://www.drugpatentwatch.com/drugs/secukinumab>.
[2] "Secukinumab (Cosentyx)" (Medication Guide). U.S. Food and Drug Administration. <https://www.fda.gov/media/94341/download>.